Health product capable of regulating health of heart and cerebral vessels and reducing risk of cardiovascular and cerebrovascular diseases
A cardiovascular and cerebrovascular disease, cardiovascular and cerebrovascular technology, applied in the direction of cardiovascular system diseases, nervous system diseases, medical preparations containing active ingredients, etc., can solve the risk of cardiovascular and cerebrovascular diseases that cannot effectively regulate cardiovascular and cerebrovascular health , poor effectiveness and safety, and inconspicuous effects, etc., to achieve the effects of remarkable prevention and treatment effects, high utilization of raw materials, and reasonable and ingenious design
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] The health product for regulating cardiovascular and cerebrovascular health and reducing the risk of cardiovascular and cerebrovascular diseases in this embodiment is composed of the following raw materials: 1 kg of L-arginine, 10 kg of hawthorn extract, 10 kg of Anemarrhena anemarrhena extract, and 10 kg of astaxanthin .
[0031] Accessories: starch 3.4kg. After the raw materials and auxiliary materials are added together, tablets are prepared according to the conventional process, each tablet is 2g.
Embodiment 2
[0033] The health product for regulating cardiovascular and cerebrovascular health and reducing the risk of cardiovascular and cerebrovascular diseases in this embodiment is composed of the following raw materials: 30g of L-arginine, 100g of hawthorn extract, 100g of Anemarrhena anemarrhena extract, and 100g of astaxanthin .
[0034] Accessories: starch 36.7g. After the raw materials and auxiliary materials are added together, capsules are prepared according to the conventional process, and each capsule is 0.8g.
Embodiment 3
[0036] The health product for regulating cardiovascular and cerebrovascular health and reducing the risk of cardiovascular and cerebrovascular diseases in this embodiment is composed of the following raw materials: 15 kg of L-arginine, 55 kg of hawthorn extract, 60 kg of anemarrhena extract, and 65 kg of astaxanthin .
[0037] Accessories: honey 20kg, citric acid 20kg, water 50kg. After adding the raw materials and auxiliary materials together, the oral liquid is prepared according to the conventional process, each 10ml.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com